JPM 2022: Bluebird CEO sees ‘unfinished business’ with Zynteglo in Europe, but scale-up needed first aarmstrong Tue, 01/11/2022 […]

JPM 2022: How Novavax plans to be a COVID-19 vaccine force in 2022 fkansteiner Tue, 01/11/2022 – 09:31

Monitoring a person’s blood pressure on a regular basis can help health care professionals with early detection of […]

Helmholtz Munich starts the new year with a triple success: Together with early-career scientists, the research center acquires […]

Over the last few weeks, the United Kingdom has experienced a record number of covid-19 infections, driven by […]

There is currently no cure for cystic fibrosis (CF), a debilitating, progressive condition with over 10,830 people in […]

The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research […]

Updated Date: Mon, 03 Jan 2022 00:00:00 EST

Updated Date: Mon, 03 Jan 2022 00:00:00 EST

Updated Date: Mon, 03 Jan 2022 00:00:00 EST